Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Feb 15, 2020; 12(2): 205-218
Published online Feb 15, 2020. doi: 10.4251/wjgo.v12.i2.205
Published online Feb 15, 2020. doi: 10.4251/wjgo.v12.i2.205
Table 4 Neuropathy symptoms identified as most bothersome by patients (n = 28), n (%)
| Symptom/issue identified as most bothersome | Number of patients who chose that symptom/issue |
| Numbness- feet | 7 (25.0) |
| Discomfort/pain- feet | 5 (17.8) |
| Cold sensitivity- eating/drinking | 4 (14.2) |
| Cold sensitivity- hands/feet | 3 (10.7) |
| Tingling- feet | 3 (10.7) |
| Loss of hand function | 2 (7.1) |
| Numbness- hands | 2 (7.1) |
| Abnormal sensation- foot | 1 (3.5) |
| Tingling- hands | 1 (3.5) |
| Trouble walking | 1 (3.5) |
| Muscle spasms- feet and legs | 1 (3.5) |
- Citation: Kaiser K, Lyleroehr M, Shaunfield S, Lacson L, Corona M, Kircher S, Nittve M, Cella D. Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale. World J Gastrointest Oncol 2020; 12(2): 205-218
- URL: https://www.wjgnet.com/1948-5204/full/v12/i2/205.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i2.205